L'Oreal Critical Wavelength Criticism Disputed By P&G
This article was originally published in The Tan Sheet
Executive Summary
L'Oreal used a "flawed technical analysis" in assessing the critical wavelength method as a UVA sunscreen testing assay, Procter & Gamble asserts in May 2 comments to FDA.
You may also be interested in...
UVA Protection Provided By 10% Of Sunscreens Tested - Researcher Diffey
Only six of 59 commercially available sunscreens met the critical wavelength standard of +/-370 nm to establish efficacy against UVA light, Brian Diffey, Newcastle General Hospital, England, et al., determine in a study published in the December Journal of the American Academy of Dermatology.
In Vivo UVA Sunscreen Tests "Clinically Irrelevant...Unethical" - Diffey
The use of in vivo methods for UVA sunscreen testing is "clinically irrelevant" and "unethical," Brian Diffey, PhD, Newcastle General Hospital, maintained at the American Association of Dermatology UVA consensus conference in Washington, D.C. Feb. 4.
FDA Extends Sunscreen Monograph Implementation Date To December 2002
The effective date of the OTC sunscreen final monograph will be extended by FDA for a year-and-a-half until Dec. 31, 2002, following a request from the Cosmetic, Toiletry & Fragrance Association, the agency says in an Oct. 1 letter to the trade group.